Abstract 3398: PTPN22 is a systemic target for augmenting antitumor immunity
Year: 2020
Type: conference-abstract
Source: Cancer Research
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3083273282
